Eczema Marketing · India · 2026 Playbook

Eczema Marketing
Agency in India.

Name: ICG · Eczema Marketing Agency in India
Author: Rohit Gupta

By Rohit Gupta · Business & Growth Lead, Ichelon Consulting Group. Reviewed by Hanuman Sihag, SEO Reviewer. Updated September 2026.

Eczema is not one condition and not one funnel. Paediatric atopic dermatitis and adult atopic dermatitis are two different marketing problems under one clinical umbrella. The parent-buyer for a child with atopic dermatitis is a completely different buyer from the 25-year-old adult managing their own eczema. This is the operator manual that treats both funnels with the seriousness each deserves — plus the steroid-safety framing that separates a credible dermatologist from the topical-steroid-abuse controversy.

Book an Eczema Marketing Diagnostic → Read the playbook →

The ICG engagement model

Every practice welcome — packages from ₹20,000/mo.

Goal-linked packages · Fixed retainer + Goal-based Variable Pay · 19-month average client retention — industry-leading. Read the full engagement model →

{-- Agency OS thumbnail · 2026-09-20 --}

🎯 Ichelon Agency OS See every goal live · client dashboard visible to you 24/7 Open the full engagement model →

Ichelon Agency OS — client health dashboard showing goal pacing across GSC, GMB, YouTube and Instagram

Backed by App\Support\NamedExperts::get(). --}}

By Rohit Gupta · Business & Growth Lead, Ichelon Consulting Group

Reviewed by Hanuman Sihag, Head of Innovation Chamber — SEO & AIO

Two funnels under one condition

The paediatric-vs-adult split.
Why one landing page cannot serve both.

Paediatric atopic dermatitis in India presents in infancy or early childhood, often overlaps with food allergy and asthma histories, and is managed for years across a shifting flare pattern. The buyer is the parent — almost always the mother — researching with high emotional stake, low tolerance for jargon, and a strong preference for clinicians who acknowledge how disruptive the condition is to daily family life. Adult atopic dermatitis presents differently — often as chronic hand eczema, seborrheic overlap, or a late-onset atopic pattern — and the buyer is the adult themselves, researching more clinically and often frustrated by years of intermittent care.

The single most common mistake in Indian eczema marketing is running one "eczema treatment" landing page for both audiences. The parent scanning the paediatric page needs age-band-specific content (infant care versus toddler versus school-age), emollient guidance, sleep-and-scratch cycle information, and a WhatsApp intake tone that reads as family-supportive. The adult scanning a serious atopic page needs a treatment-ladder explainer that goes deep on dupilumab, information on hand eczema and occupational triggers, and clinical language.

Both funnels need separate landing pages, separate creative treatments, and separate WhatsApp intake scripts. The clinics that make this split consistently see 30 to 60 per cent higher conversion on both funnels than clinics running a merged eczema page.

The parent-buyer

Mother-as-researcher, WhatsApp intake, evening-hour consults.
The paediatric funnel operating rhythm.

The mother researching for a child with atopic dermatitis follows a distinctive pattern: research happens in evening or late-evening hours, WhatsApp enquiries land between 21:00 and 23:30 IST at nearly twice the rate of daytime, consult booking preferences skew heavily to evening slots or Saturdays. A paediatric-atopic-heavy practice that does not offer evening or Saturday paediatric-focused slots loses meaningful volume to competitors that do.

The WhatsApp intake for a paediatric enquiry needs a warmer, more measured opening than an acne or adult-atopic intake. "Thank you for reaching out about your child. Whenever you are ready, we would love to understand what has been happening" sets the tone. The three-question script — child's age, area affected, how long — is delivered across two messages rather than in one bullet-list block. A pre-consultation link to an emollient guide or a flare-management explainer builds credibility before the consult itself.

The content architecture for the paediatric funnel: a hub page on paediatric atopic dermatitis (age-band-specific care), spokes on emollient selection, flare-management, food-allergy overlap, sleep-and-scratch cycles, and school-age management. The tone across every page treats the parent as a partner in the child's care, not as a lead to be captured.

Flare-management content

Seasonal, humidity-linked, geography-specific.
The content that carries retention.

Eczema flares track climate. Winter dry-cold flares dominate North India from October to February. Monsoon humidity flares dominate coastal metros from June to September. Air-conditioned indoor exposure produces year-round low-grade flares in metro tech corridors. The dermatology practice that publishes flare-management content mapped to the seasonal calendar of its catchment retains meaningfully better than one that treats eczema as a static condition.

The seasonal content stack for a North India practice: a winter dry-cold flare guide published in early October, a Diwali-week guide on air-quality-linked flares, a January humidifier-and-emollient guide, and a March seasonal-transition guide. For a coastal metro (Chennai, Mumbai, Kolkata): a pre-monsoon June guide on humidity flares, a mid-monsoon August fungal-adjacent-flare guide, and a post-monsoon October guide on transitioning care. Each piece dermatologist-authored, evidence-cited, and shareable to the existing patient base via WhatsApp broadcast.

The WhatsApp broadcast to the existing patient base at seasonal transitions is a retention lever most clinics under-use. A pre-winter broadcast sent to every paediatric-atopic patient's parent in the last week of September, containing the winter flare guide plus a soft booking nudge for a preventive review, produces 15 to 35 per cent booking uptake on the broadcast in our portfolio — capturing follow-ups that would otherwise wait until a flare is already active.

Steroid-safety framing

How to educate without triggering the topical-steroid-abuse controversy.
The compliance craft.

Topical steroids are the most-searched and most-controversial category of topical dermatology treatment in India. The topical-steroid-abuse conversation — driven by unregulated over-the-counter steroid creams, cosmetic misuse, and steroid-atrophy cases circulating on Instagram and Reddit — has produced a patient base that is both fearful of and confused about legitimate prescription steroid use in atopic dermatitis.

The dermatology practice that handles this well earns compounding trust. The compliant framing: educate on potency classes (mild, moderate, potent, super-potent), on appropriate use (short courses under supervision, correct area application, weaning protocols), and on the distinction between prescription-supervised use and the over-the-counter steroid-cream abuse pattern. Never advocate for indefinite topical steroid use. Never dismiss patient concerns about steroids. Never publish content that reads as defensive of the pharmaceutical industry rather than protective of the patient.

The content stack: a hub page on topical steroids in atopic dermatitis (potency classes, evidence-based use, safety, weaning), a spoke on the difference between supervised prescription use and OTC abuse, a spoke on steroid-sparing alternatives (topical calcineurin inhibitors, topical PDE4 inhibitors, dupilumab for severe cases), and an FAQ page on the specific concerns parents raise (skin-thinning, dependence, growth effects). Each page named-authored, evidence-cited, and written in language that respects the patient's concerns.

Dupilumab and the adult expansion

The new adult-eczema category.
Biologic content architecture.

Dupilumab (IL-4/IL-13 receptor antagonist) has expanded the adult atopic dermatitis category in India substantially since biosimilar availability improved and awareness grew. Moderate-to-severe adult atopic patients — previously cycling through cyclosporine, methotrexate and topical potent steroids with poor long-term outcomes — now have a targeted biologic option. Awareness of the category doubles every 12 to 18 months in Indian search data.

The content architecture for a practice serious about adult atopic: a hub page on adult atopic dermatitis, a spoke on dupilumab (mechanism, indications, dosing, monitoring, cost-band, insurance coverage picture), a spoke on hand eczema and occupational eczema, and a spoke on the treatment ladder from topicals through systemic to biologic. The compliance frame is molecule-education not brand-comparison, and every claim is evidence-cited.

The CGHS and private-insurance coverage picture for dupilumab has expanded in 2025-26. Display the current coverage clearly on the dupilumab spoke page. The researching adult atopic patient — often after years of frustrating intermittent care — treats the coverage-transparency signal as a serious credibility marker.

Retention economics

Chronic-care LTV over 3 to 5 years.
The teleconsult adjacency.

A paediatric atopic patient managed well across childhood contributes Rs.40,000 to Rs.90,000 in clinical revenue over a 3-to-5-year relationship. An adult atopic patient on dupilumab contributes Rs.60,000 to Rs.1.2 lakh over a similar window. Both compound the family-referral network — the mother who trusts the paediatric dermatologist with one child usually returns with siblings, and often with her own dermatology enquiries within two years.

The retention SOP that captures this LTV: seasonal flare-management broadcasts (October and June-July), quarterly WhatsApp check-ins for chronic-care paediatric patients, an annual review nudge in November, a teleconsult offer for out-of-station follow-ups, and a family-member cross-referral prompt at the six-month mark for parent-buyers whose child's condition is stabilised.

Teleconsult is a genuine acquisition and retention channel for eczema, particularly for paediatric atopic where a parent may prefer an evening 20-minute video review over a clinic visit for a stable case. A paediatric-atopic practice that offers evening teleconsult slots as a first-line option for stable-flare reviews and reserves in-person for acute presentations retains 20 to 40 per cent better than one that treats teleconsult as an afterthought.

Frequently asked

About eczema marketing
in India.

The compliance frame for paediatric atopic marketing is educational and family-supportive rather than promotional. Publish age-band-specific content on care, emollient selection, flare management and sleep-scratch cycles. Never guarantee outcomes for a child. Never use before-and-after imagery. Never make comparative superiority claims. The WhatsApp intake tone should read as clinical-supportive, not sales-driven. NMC Section 6 applies to paediatric content the same way it applies to adult content — the paediatric context adds a community-sensitivity layer that reinforces the same restrictions.

Teleconsult is a genuine acquisition and retention channel for paediatric atopic dermatitis. Parents managing a stable case often prefer a 20-minute evening video review over a clinic visit, and the parent-buyer decision-cycle is more comfortable initiating care via teleconsult than the adult-buyer for other verticals. Practices offering evening teleconsult slots as a first-line option for stable-flare reviews (reserving in-person for acute presentations) retain 20 to 40 per cent better and often see 10 to 25 per cent of new paediatric enquiries initiate as teleconsult before converting to a physical review.

Handled well, it compounds trust. The topical-steroid-abuse conversation is happening on Instagram, Reddit and community forums regardless of whether a clinic engages with it. A dermatologist who publishes clear, evidence-based educational content on potency classes, appropriate supervised use, weaning protocols and the distinction between prescription-supervised use and OTC steroid-cream abuse earns credibility from the researching parent. A dermatologist who avoids the conversation or dismisses patient concerns cedes trust to whoever else is answering the question.

Paediatric atopic dermatitis: Rs.40,000 to Rs.90,000 across a 3-to-5-year relationship, with meaningful family-referral compounding (siblings, mother's own dermatology enquiries). Adult atopic dermatitis on dupilumab: Rs.60,000 to Rs.1.2 lakh across a similar window. Adult atopic on non-biologic management (topicals plus systemic): Rs.20,000 to Rs.55,000 across 3 to 5 years. All three compound if the retention SOP executes on the seasonal flare-management calendar.

In our portfolio: organic search (roughly 40 to 55 per cent of paediatric enquiries), Meta Reels and organic Instagram (20 to 30 per cent), Google Ads (10 to 18 per cent), paediatrician and family-physician referrals (10 to 20 per cent), and existing-patient word-of-mouth (5 to 15 per cent). The organic-search dominance reflects the parent's research pattern — evening deep-reading before initiating a WhatsApp enquiry.

As molecule-education, not brand-comparison. A page titled 'Understanding dupilumab for moderate-to-severe atopic dermatitis' with content on mechanism (IL-4/IL-13 receptor antagonism), indications (moderate-to-severe atopic dermatitis where topical and systemic therapy has been inadequate), dosing schedule, monitoring, cost-band range and current insurance coverage picture is compliant. A page titled 'Dupixent versus [another brand] — which is better for eczema?' is not. The compliant framing lets the researching patient understand the category and arrive at the consultation ready to have the biologic conversation.

Twice-yearly seasonal broadcasts (early October pre-winter, mid-June pre-monsoon for North India; adjusted regionally for coastal metros), plus one November annual-review nudge for patients who have not booked in six months. Broadcasts contain the season's flare-management guide plus a soft booking nudge — never a promotional offer or discount. Broadcast uptake typically produces 15 to 35 per cent booking within 10 days of send, capturing follow-ups that would otherwise wait until a flare is already active.

The ICG technology stack

Nine tools. One compounding system. HealthApex OS
Built in-house. Deployed in every engagement.

ICG's results are reproducible because they are built on proprietary infrastructure — not agency intuition or generic tools. These nine HealthApex OS platforms are what power every ICG engagement.

Healthcare CRM

Nexus CRM

Healthcare CRM & Lead Management

ICG's healthcare-specific CRM and lead management system. Specialty-configured funnel stages for IVF, dental, aesthetic, ortho, hospital OPD. 1-click CAPI + GCLID via Beacon. Hawk intelligence built in. DPDP-compliant by architecture. Deployed across 300+ healthcare centres.

Specialty-specific funnel stages, not generic SaaS pipeline
1-click CAPI + GCLID via Beacon attribution
Telecaller leaderboard + adherence scoring native
DPDP Act 2023 compliant by architecture

Explore Nexus CRM →

Business Layer

Hawk

CRM Intelligence & Lead-Ops MIS

Sits as the business intelligence layer above your CRM — Nexus, Salesforce, LeadSquared, HubSpot, Zoho, or any custom CRM. Shows where leads are leaking, which effort is wasted, and which good leads were quietly downgraded by automation — not by a human decision.

Sits above your existing LMS — no replacement
83% of effort goes to dead leads — surfaced Day 1
~75% qualified-lead downgrades by automation
Free Lead-Leak Audit in 48 hours

Explore Hawk + free audit →

Attribution Core

Beacon

Attribution Engine & CAPI Middleware

Sits at the centre of every ICG attribution architecture. CAPI middleware connecting Meta Ads, Google Ads, WhatsApp and IVR to your CRM. Lifts Event Match Quality from 2.5 to 6+, reducing CPM 30–40% from the same budget.

Server-side CAPI — bypasses iOS privacy changes
EMQ 2.5 → 6+ across portfolio
30–40% CPM reduction from EMQ lift alone
Multi-touch: ad → consultation → revenue

Explore Beacon →

Practice Management

HealthPro 360

PMS with built-in revenue intelligence layer

The only PMS that tracks cross-sell and up-sell opportunities within your existing patient base. 12 modules covering OPD, IPD, Pharmacy, Labs, Billing, Inventory, Patient Portal, Smart Scheduling, RBAC, AES-256 encrypted storage.

Only PMS with built-in Revenue Intelligence
Cross-sell signal tracking within existing patients
12 modules: OPD, IPD, Pharmacy, Labs, Billing+
Audit trails + RBAC + AES-256 encryption

Explore HealthPro 360 →

Revenue Layer

Phoenix

Revenue intelligence built over your existing PMS

If you already have a PMS — Akhil Systems, Practo, or any other — Phoenix builds the business intelligence layer on top of it without replacement. Currently live across 46 centres for a national chain.

Works over your existing PMS — no migration
Daily action queue: Prevent Loss / Maintain / Grow
Catches unbilled services, collection gaps, lapsing patients
CPQL variance ₹620–₹3,800 → ₹680–₹1,420

Explore Phoenix →

YouTube Intelligence

YODA

YouTube analytics that measures patients, not views

The only YouTube intelligence platform built for healthcare business outcomes. Connects video performance to actual consultation bookings — not views, not subscribers. Patient testimonial videos generate 6.9× more consultations per view than condition explainers.

Consultation attribution per video — not views
Demand-gap: what patients search that your channel misses
50+ doctor channels tracked across India
AIO readiness scoring: which videos AI tools cite

Explore YODA →

Governance & Transparency

Agency OS

Full transparency. Instant diagnosis. Zero surprises.

ICG's centralised governance platform — every client sees everything in real time, and ICG's team sees every problem the moment it surfaces. 30+ real-time alert systems fire the moment a metric drifts outside its performance envelope.

GSC, GA4, Google Ads, Meta Ads, IVR — one live view
30+ real-time alert systems per account
CPQL drift alert at >15% week-on-week change
Client login: full transparency on your account

Explore Agency OS →

AEO & LLM Intelligence

AIO Intel

AI Overview + LLM citation tracking, healthcare-tuned

Knows the moment ChatGPT, Perplexity, Google AI Overviews and Gemini cite your brand in patient answers — and which content drove the citation. Bot-aware dashboard with GA4-registered custom dims (AIO source, AIO referrer) and IndexNow + GSC API integration.

Live tracking across ChatGPT / Perplexity / Google AIO / Gemini
Bot-aware: knows human vs scraper traffic
Custom GA4 dims register AIO source + referrer
IndexNow + GSC API: content surfaced to LLMs within hours

View AIO Intel dashboard →

Competitor Intelligence

Prism Spy

Every Meta + Google ad your competitors run, watched daily

Tracks 75+ Indian healthcare brands, 2,150+ active ads, ₹50Cr+ aggregate ad spend visibility per month. Surfaces what's working, what's been killed, what offers are emerging. Powers every ICG Meta Ads brief, Performance Marketing diagnostic, and IVF / derm / dental specialty campaign with real competitive intelligence.

75+ brands tracked across 30+ healthcare specialties
2,150+ active ads · daily refresh
Activity Feed: every spend / hook / pause logged
Offers Intelligence: 250+ offers in market tracked

Explore Prism Spy →

GBP Intelligence Platform

Angryturtle

Every Google Business Profile scored, tracked, protected, and grown from one command centre

ICG's proprietary Google Business Profile intelligence platform. Scores every listing across 7 dimensions, tracks rank on a live geo-grid across your actual service area, audits NAP + citations, monitors 531 suspension-risk factors continuously, and drafts Google Posts on cadence. Currently managing 143 healthcare listings with 0 suspensions and 4.76★ portfolio average across 28,137 reviews.

143 listings under management · 0 suspensions · 4.76★
7-dimension Health Score + 5-factor Rank OS per listing
Geo-grid rank tracking + NAP + Citation audit + Profile Shield
NMC + NABH + ART Act + DPDP compliance built into every content + review workflow

Explore Angryturtle →

Every ICG engagement runs on some combination of these ten HealthApex OS tools. The diagnostic determines which combination is right for your practice.

Explore HealthApex OS → See the full stack live on your account — free 30-min audit →

The team behind your account

Every diagnostic is led by a founder.
You'll know their names before the engagement begins.

ICG was built by three IIT BHU engineers who entered healthcare marketing with a specific intent: to build the tools that didn't exist and run the campaigns that most agencies couldn't. When you book a diagnostic, Rohit or Abhash leads it personally. Not an account manager. Not a senior executive. The people who built what you're evaluating.

The ICG team — 60+ healthcare marketing specialists at Gurgaon HQ

60+ specialists.
One growth engine.

Performance marketers, analysts, AI engineers, content strategists, and operations specialists — all healthcare-only. Headquartered in Gurgaon since 2018.

Rohit Gupta

Business & Growth Lead & Director

IIT BHU · IIM Rohtak

Rohit's first question in every diagnostic: "When you ask your agency why patients aren't booking — what do they say?" He says the answer tells him more than any dashboard.

Full profile →

Abhash Kumar

Strategy & Analytics Lead & Director

IIT BHU · IIM Bangalore

Abhash built Beacon because most agencies couldn't answer one question: "Which of my campaigns generated that consultation?" He decided the problem was solvable in code. It was.

Full profile →

Deep Das

Technology & AI Lead & Director

IIT BHU

Deep built the 4-Bot patient lifecycle system after watching a client lose 60+ qualified leads in one week to a 6-hour WhatsApp response window. He decided the problem was solvable in code. It was.

Full profile →

Book a diagnostic with the Co-Founding Team → Meet the full leadership team →

Ready to build an
eczema paediatric + adult engine?

Start with a complimentary 30-minute Eczema Marketing Diagnostic from ICG. For dermatologists serving families and chronic-care adult atopic patients. Sibling reads: dermatology pillar, psoriasis marketing, aesthetic dermatology hub.

Book a Diagnostic → Dermatology pillar →

Eczema MarketingAgency in India.

The paediatric-vs-adult split.Why one landing page cannot serve both.

Mother-as-researcher, WhatsApp intake, evening-hour consults.The paediatric funnel operating rhythm.

Seasonal, humidity-linked, geography-specific.The content that carries retention.

How to educate without triggering the topical-steroid-abuse controversy.The compliance craft.

The new adult-eczema category.Biologic content architecture.

Chronic-care LTV over 3 to 5 years.The teleconsult adjacency.

About eczema marketingin India.

Nine tools. One compounding system. HealthApex OSBuilt in-house. Deployed in every engagement.

Nexus CRM

Hawk

Beacon

HealthPro 360

Phoenix

YODA

Agency OS

AIO Intel

Prism Spy

Angryturtle

Every diagnostic is led by a founder.You'll know their names before the engagement begins.

60+ specialists.One growth engine.

Rohit Gupta

Abhash Kumar

Deep Das

Ready to build aneczema paediatric + adult engine?

Hi, I'm Rohit. Co-Founder, ICG.

Eczema Marketing
Agency in India.

The paediatric-vs-adult split.
Why one landing page cannot serve both.

Mother-as-researcher, WhatsApp intake, evening-hour consults.
The paediatric funnel operating rhythm.

Seasonal, humidity-linked, geography-specific.
The content that carries retention.

How to educate without triggering the topical-steroid-abuse controversy.
The compliance craft.

The new adult-eczema category.
Biologic content architecture.

Chronic-care LTV over 3 to 5 years.
The teleconsult adjacency.

About eczema marketing
in India.

Nine tools. One compounding system. HealthApex OS
Built in-house. Deployed in every engagement.

Every diagnostic is led by a founder.
You'll know their names before the engagement begins.

60+ specialists.
One growth engine.

Ready to build an
eczema paediatric + adult engine?